A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Clinical trial NCT07409181 · RECRUITING
Trial details
- NCT number
- NCT07409181
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2029-02-04
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.